Tharimmune Inc (THAR)

[BooDog]

... today announced the pricing of an underwritten public offering of 5,300,000 shares of its common stock. Each share is being sold to the public at a price of $0.50 for gross proceeds of $2,650,000, before deducting underwriting discounts and offering expenses.
https://finance.yahoo.com/news/hillstream-biopharma-announces-pricing-public-015000928.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAI4_s1gJ5aGKMrMChVdUMZq0KE9mQr_qZxTL76DKHrUgaMbxihXgHzuUtp95N2bQ-Mi1jnybno-kFwNEkKM-evYvLf_H4mhf1gBYnFNXrS8CCaYZqaBzxfsF1to7KOd-kFqz5OEMAFY6TLuCz0YbAyRmoKlAmA9qZQmOaekibALD

Have to say, this is all to easy to predict when a bio makes a move like HILS did. At least sometimes they do it with real news first and then after it sustains a decent run then the offering is announced a little higher than before the run started. Maybe a bit of speculation here but after watching BXRX do it, and now CFRX did their news I'm just waiting for their offering to post.